Found 60 matching trials
An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD) PHASE4 The purpose of this study is to evaluate the safety and efficacy of Osmotic...
Show More Location
Multiple Locations
Learn More & Join Trial
Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release Methylphenidate PHASE4 This is a single-blind study looking at the efficacy and satisfaction of Co...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder PHASE3 The purpose of this study is to evaluate the efficacy of 2 fixed dosages of...
Show More Location
Multiple Locations
Learn More & Join Trial
Study Examining Repeat Dosing of OROS® Methylphenidate (CONCERTA®) and Immediate Release Methylphenidate in Healthy Adults PHASE3 There are two specific aims of this study. The first is to document the pha...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Benefits of ADHD Treatment in Detained People PHASE3 Attention deficit hyperactivity disorder (ADHD) is characterized by difficu...
Show More Location
Geneva University Hospitals
Learn More & Join Trial
Quetiapine and Concerta in the Treatment for ADHD and Aggressive Behavior. PHASE2 The primary purpose of this thirteen-week, open-label study is to test the ...
Show More Location
Riley Childrens Hospital
Learn More & Join Trial
Prevention of Cigarette Smoking in Attention Deficit Hyperactivity Disorder (ADHD) Youth With Concerta PHASE4 This study will consist of a six-week open-label treatment period with an e...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
A Multicenter Study Comparing the Efficacy and Safety of OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder PHASE3 The purpose of this study is to evaluate the efficacy and safety of OROS® ...
Show More Location
Multiple Locations
Learn More & Join Trial
Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD) PHASE4 The purpose of this study is to determine whether norepinephrine gene polym...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Genetic Polymorphism and OROS-Methylphenidate Treatment in Attention Deficit Hyperactivity Disorder(ADHD) PHASE4 The purpose of this study is to examine whether genetic polymorphisms in dr...
Show More Location
Bundang CHA hospital
Learn More & Join Trial